FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention refers to pharmaceutical industry, namely to (R)-enantiomer of pirlindole or its pharmaceutically acceptable salt for therapeutic treatment and prevention of neuropathic pain. Use of (R)-enantiomer of pirlindole or its pharmaceutically acceptable salt for therapeutic treatment or prevention of neuropathic pain. Pharmaceutical composition for treating neuropathic pain comprising (R)-enantiomer of pirlindole or its pharmaceutically acceptable salt.
EFFECT: disclosed is (R)-enantiomer of pirlindole or a pharmaceutically acceptable salt thereof being an effective agent for treating or preventing neuropathic pain with fewer side effects with preserving analgesic activity.
6 cl, 5 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
(S)-PIRLINDOLE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS FOR USE IN MEDICINE | 2014 |
|
RU2695647C2 |
NEW PREVENTIVE AND/OR THERAPEUTIC AGENT FOR NEUROPATHIC PAIN | 2008 |
|
RU2462459C2 |
COMPOSITIONS COMPRISING TRAMADOL AND CELECOXIB FOR TREATING PAIN | 2010 |
|
RU2707752C2 |
NEW THERAPEUTIC COMBINATIONS OF MIRTAZAPINE APPLICABLE IN PAIN CONDITIONS | 2013 |
|
RU2509560C1 |
PHARMACEUTICAL COMPOSITIONS OF SPIRO-OXINDOLE COMPOUND FOR LOCAL ADMINISTRATION AND USE THEREOF AS THERAPEUTIC AGENTS | 2011 |
|
RU2596488C2 |
4-(PHENYLMETHYL AND SUBSTITUTED-PHENYLMETHYL)-IMIDAZOLE-2-THIONIES, ACTING AS SPECIFIC ALPHA-ADRENERGIC AGONISTS | 2005 |
|
RU2383535C2 |
METHOD AND COMPOSITIONS FOR PAIN RELIEF | 2003 |
|
RU2329062C2 |
ENANTIOMERS OF SPIRO-OXINDOLE COMPOUNDS AND USING THEM AS THERAPEUTIC AGENTS | 2010 |
|
RU2535667C2 |
APPLICATION OF RETIGABIN FOR TREATING NEUROPATHIC PAINS | 2000 |
|
RU2264813C2 |
-E-10-OH-NT COMPOSITIONS AND METHOD FOR SYNTHESIS AND USE THEREOF | 2008 |
|
RU2469715C2 |
Authors
Dates
2019-07-24—Published
2014-05-09—Filed